Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

mRNA display: from basic principles to macrocycle drug discovery.

Josephson K, Ricardo A, Szostak JW.

Drug Discov Today. 2014 Apr;19(4):388-99. doi: 10.1016/j.drudis.2013.10.011. Epub 2013 Oct 22. Review.

PMID:
24157402
2.

Construction and screening of vast libraries of natural product-like macrocyclic peptides using in vitro display technologies.

Bashiruddin NK, Suga H.

Curr Opin Chem Biol. 2015 Feb;24:131-8. doi: 10.1016/j.cbpa.2014.11.011. Epub 2014 Dec 5. Review.

3.

Comparison of mRNA-display-based selections using synthetic peptide and natural protein libraries.

Huang BC, Liu R.

Biochemistry. 2007 Sep 4;46(35):10102-12. Epub 2007 Aug 9.

PMID:
17685586
4.

Technologies for the synthesis of mRNA-encoding libraries and discovery of bioactive natural product-inspired non-traditional macrocyclic peptides.

Ito K, Passioura T, Suga H.

Molecules. 2013 Mar 18;18(3):3502-28. doi: 10.3390/molecules18033502. Review.

5.

Macrocycles as protein-protein interaction inhibitors.

Dougherty PG, Qian Z, Pei D.

Biochem J. 2017 Mar 15;474(7):1109-1125. doi: 10.1042/BCJ20160619. Review.

PMID:
28298556
6.

A novel strategy for in vitro selection of peptide-drug conjugates.

Li S, Roberts RW.

Chem Biol. 2003 Mar;10(3):233-9.

7.

Selection-based discovery of druglike macrocyclic peptides.

Passioura T, Katoh T, Goto Y, Suga H.

Annu Rev Biochem. 2014;83:727-52. doi: 10.1146/annurev-biochem-060713-035456. Epub 2014 Feb 21. Review.

PMID:
24580641
8.

The exploration of macrocycles for drug discovery--an underexploited structural class.

Driggers EM, Hale SP, Lee J, Terrett NK.

Nat Rev Drug Discov. 2008 Jul;7(7):608-24. doi: 10.1038/nrd2590. Review.

PMID:
18591981
9.

Lead discovery and optimization strategies for peptide macrocycles.

Bhat A, Roberts LR, Dwyer JJ.

Eur J Med Chem. 2015 Apr 13;94:471-9. doi: 10.1016/j.ejmech.2014.07.083. Epub 2014 Jul 24. Review.

PMID:
25109255
10.

In-vitro protein evolution by ribosome display and mRNA display.

Lipovsek D, Pl├╝ckthun A.

J Immunol Methods. 2004 Jul;290(1-2):51-67. Review. Erratum in: J Immunol Methods. 2004 Nov;294(1-2):213.

PMID:
15261571
11.

In vitro selection of protein and peptide libraries using mRNA display.

Takahashi TT, Roberts RW.

Methods Mol Biol. 2009;535:293-314. doi: 10.1007/978-1-59745-557-2_17.

PMID:
19377989
12.

Designing scaffolds of peptides for phage display libraries.

Uchiyama F, Tanaka Y, Minari Y, Tokui N.

J Biosci Bioeng. 2005 May;99(5):448-56. Review.

PMID:
16233816
13.

Past and future perspectives of synthetic peptide libraries.

Marasco D, Perretta G, Sabatella M, Ruvo M.

Curr Protein Pept Sci. 2008 Oct;9(5):447-67. Review.

PMID:
18855697
14.

In vitro selection of multiple libraries created by genetic code reprogramming to discover macrocyclic peptides that antagonize VEGFR2 activity in living cells.

Kawakami T, Ishizawa T, Fujino T, Reid PC, Suga H, Murakami H.

ACS Chem Biol. 2013;8(6):1205-14. doi: 10.1021/cb300697h. Epub 2013 Apr 2.

PMID:
23517428
15.

Detection of small-molecule enzyme inhibitors with peptides isolated from phage-displayed combinatorial peptide libraries.

Hyde-DeRuyscher R, Paige LA, Christensen DJ, Hyde-DeRuyscher N, Lim A, Fredericks ZL, Kranz J, Gallant P, Zhang J, Rocklage SM, Fowlkes DM, Wendler PA, Hamilton PT.

Chem Biol. 2000 Jan;7(1):17-25.

16.

Natural peptides to drugs - fourth international congress.

Leone-Bay A.

IDrugs. 2010 Jun;13(6):369-71.

PMID:
20506056
17.

In vitro selection of highly modified cyclic peptides that act as tight binding inhibitors.

Schlippe YV, Hartman MC, Josephson K, Szostak JW.

J Am Chem Soc. 2012 Jun 27;134(25):10469-77. doi: 10.1021/ja301017y. Epub 2012 Mar 29.

18.

Phage display as a technology delivering on the promise of peptide drug discovery.

Hamzeh-Mivehroud M, Alizadeh AA, Morris MB, Church WB, Dastmalchi S.

Drug Discov Today. 2013 Dec;18(23-24):1144-57. doi: 10.1016/j.drudis.2013.09.001. Epub 2013 Sep 17. Review.

PMID:
24051398
19.

Phage display: concept, innovations, applications and future.

Pande J, Szewczyk MM, Grover AK.

Biotechnol Adv. 2010 Nov-Dec;28(6):849-58. doi: 10.1016/j.biotechadv.2010.07.004. Epub 2010 Jul 23. Review.

PMID:
20659548
20.

Peptide inhibitors of botulinum neurotoxin by mRNA display.

Yiadom KP, Muhie S, Yang DC.

Biochem Biophys Res Commun. 2005 Oct 7;335(4):1247-53.

PMID:
16122707

Supplemental Content

Support Center